CVS Health (NYSE:CVS) Receives a Downgrade
Shares of CVS Health (NYSE:CVS) were lowered to a “Neutral” by analysts at Goldman. CVS’s rating of a “Buy” has been discontinued.
From a total of 21 analysts covering CVS Health (NYSE:CVS) stock, 22 rate it a ”Buy”, 0 a “Sell”, and 3 a ”Hold”. This means that 88% of the ratings are positive. The highest target price is $132 while the lowest target price is $105. The mean of all analyst targets is $116.19 with a 22.22% above today’s ($96.14) stock price. CVS Health was the topic of 12 analyst reports since July 22, 2015 according to the firm StockzIntelligence Inc. S&P Research maintained shares on November 2 with “Strong Buy” rating. Evercore reinitiated shares with “Buy” rating and $118 target share price in a report from an August 19. JP Morgan maintained CVS stock in a recent report from November 2 with “Overweight” rating. Argus Research maintained the rating on August 10. Argus Research has a “Buy” rating and a $118.0 price target on shares. Finally, Deutsche Bank maintained the stock with “Hold” rating in a report issued on an August 20.
Approximately 2.60 million shares of stock traded hands. CVS Health Corp (NYSE:CVS) has declined 4.32% since May 14, 2015 and is downtrending. It has underperformed by 2.05% the S&P500.
The overall sentiment of institutions has increased to 1.21 in Q2 2015. Its up 0.15, from 1.06 in 2015Q2. The ratio is positive, as 62 institutions have sold all the shares of CVS Health Corp that they owned while 529 funds have taken shares off the table. 104 funds have purchased shares for the first time while 611 added to their positions. These institutions now hold 922.81 million shares or 0.74% more than the 916.04 million shares they owned in 2015Q2.
The Fund Dsc Advisors L.P. currently is holding shares equating to 10.2% of its total portfolio in CVS Health Corp representing a total of 217,919 shares. Another fund,Kdi Capital Partners Llc, is holding a total of 292,305 shares equating to 8.2% of their holdings. Additionally, Cabot has a 135,106 share stake in CVS Health Corp which represents 7.84% of their total portfolio. The Fund, Cortland Associates Inc Mo, based out of Missouri, has also built up a stake in the stock, which represents a total of 7.82% of their total portfolio. Finally Veritas Investment Management Llp, a fund which is based in the state of United Kingdom reported a total holdings of 349,411 shares.
Insider activity is a very important aspect to track on any stock. Going back to March 23, 2015, shareholders of CVS Health Corp have witnessed 0 buys, and a total of 2 sales equating to a net activity of approximately $7.93 million . Boratto Eva C sold 22,107 shares worth approximately $2.44M. Bisaccia Lisa sold 49,908 shares worth approximately $5.49M. Sussman Andrew sold 17,638 shares worth approximately $1.81 million. Brennan Troyen A sold 33,384 shares worth approximately $3.42 million. The company insider Brown C David Ii sold 25,000 shares worth $2.61M.
CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The company has a market cap of $107.69 billion. The Firm operates through three business divisions: Pharmacy Services, Retail Pharmacy and Corporate. It has 21.61 P/E ratio. The Pharmacy Services segment provides a range of pharmacy benefit management services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.
According to Zacks Investment Research, “CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.”